ArticleTherapeutic innovation & regulatory science2022

A Comparison of Safety Information in Drug Labeling at the Initial Approval of New Drugs Approved Both in Japan and the United States.

Yuko Hoshino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.